Lumida
/DERM
⌘K
Journey Medical Corp

Journey Medical Corp

DERM
$7.23USD+1.97%+0.14 today

MARKET CAP

204.1M

P/E (TTM)

FWD P/E

DAY RANGE

$7 – $7

52W RANGE

$4
$10

AI Summary

Stalk
Sell NowMedium

DERM remains in early Stage 1 consolidation following a terminal decline and range-bound repair. A late-June breakout failed, evidenced by a Bullish Exhaustion candle, and price is overbought and facing resistance. This leads to a bearish medium-term bias, recommending selling into strength near the breakout region.

  • Q2 2026 revenue of $18.5M up 23% YoY; Adjusted EBITDA positive $2.9M
  • MROSI uptake reached ~36,000 prescriptions, contributing $8.1M revenue
  • Q2 net loss of $0.3M and negative earnings yield signal profit challenges
Full analysis →
Insider Trades12 trades
DateSideTickerInsiderRoleSharesPriceMkt Cap52W High52W LowValue% ChgRuleAI View
Aug 25, 2025BuyDERMClaude MaraouiPresident & CEO1,260,877$0.13$204.1M-24.33%+67.75%$162.5K+34.95%Sell Now
May 2, 2025SellDERMJoseph BeneschCFO2,409$6.84$204.1M-24.33%+67.75%$16.5K-1.17%Sell Now
May 2, 2025SellDERMRamsey AlloushCOO2,857$6.84$204.1M-24.33%+67.75%$19.5K-0.56%Sell Now
May 2, 2025SellDERMClaude MaraouiPresident & CEO4,834$6.84$204.1M-24.33%+67.75%$33.1K-0.21%Sell Now
Mar 11, 2025SellDERMClaude MaraouiPresident & CEO49,271$5.01$204.1M-24.33%+67.75%$246.8K-2.40%Sell Now
Mar 6, 2025SellDERMClaude MaraouiPresident & CEO40,456$5.03$204.1M-24.33%+67.75%$203.5K-0.97%Sell Now
Mar 3, 2025SellDERMClaude MaraouiPresident & CEO70,556$5.11$204.1M-24.33%+67.75%$360.8K-1.10%Sell Now
Feb 21, 2025SellDERMJoseph BeneschCFO1,365$5.19$204.1M-24.33%+67.75%$7.1K-2.88%Sell Now
Aug 1, 2024SellDERMJoseph BeneschCFO9,324$5.47$204.1M-24.33%+67.75%$51.0K-16.46%Sell Now
Jul 23, 2024SellDERMJoseph BeneschCFO4,055$5.40$204.1M-24.33%+67.75%$21.9K-6.68%Sell Now
Mar 22, 2024BuyDERMClaude MaraouiPresident & CEO10,000$3.48$204.1M-24.33%+67.75%$34.8K+0.46%Sell Now
Feb 22, 2024SellDERMJoseph BeneschInterim CFO2,450$3.75$204.1M-24.33%+67.75%$9.2K-3.88%Sell Now